Radiopharm Theranostics Files 6-K
Ticker: RDPTF · Form: 6-K · Filed: Jul 16, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory
TL;DR
Radiopharm Theranostics filed a 6-K on 7/16/25, standard foreign issuer report.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on July 16, 2025, reporting information for the month of July 2025. The company is a foreign private issuer and is not furnishing information under Rule 12g3-2(b).
Why It Matters
This filing indicates routine reporting for a foreign private issuer, providing transparency on their regulatory compliance and information dissemination to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Numbers
- 001-41621 — SEC File Number (Identifies the company's registration with the SEC.)
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — Commission File Number
- July 2025 (date) — Reporting period
- 20250716 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information which the issuer has made or is required to make public pursuant to the laws of the issuer's home country or jurisdiction, or a stock exchange on which it is listed, or that it has distributed or will distribute to its security holders.
Is Radiopharm Theranostics Limited a US-based company?
No, Radiopharm Theranostics Limited is a foreign private issuer, as indicated by the Form 6-K filing and its Australian address.
Does this filing indicate an annual report submission?
No, this is a Form 6-K, which is a report of foreign private issuer, not an annual report (which would typically be Form 20-F for this company).
What is the filing date of this report?
The filing date of this Form 6-K is July 16, 2025.
Is Radiopharm Theranostics providing information under Rule 12g3-2(b)?
No, the box indicating 'Yes' for Rule 12g3-2(b) is not checked, meaning the registrant is not furnishing information under that specific rule.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 16, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).